3D printing Paracetamol tablets

British scientists expand the research potential for “Printlets”

By its own account, the British company FabRx is the world’s first research group to use 3D printing technology to print medicines. The 3D printed tablets they produce are called “Printlets”. The idea is to make medicines more attractive to various groups of patients and thereby facilitate compliance with treatment. Inspired by the success of their method, the British scientists have purchased another medicine printer by the Swiss company Sintratec.

FabRx, a spin-out company of University College London (UCL), uses the “Sintratec Kit” – an SLS (selective laser sintering) 3D printer – to produce its Printlets. According to the manufacturer, the “Sintratec Kit” SLS 3D printer is the perfect choice for temperature-sensitive materials because it enables users to finely adjust and monitor parameter settings such as laser speed and material temperature.

Making the Printlets more palatable to children

This allows different drug combinations and doses to be printed in any size, and with different shapes, sizes, colors, and textures, which makes the Printlets more palatable to children and easier to consume for the elderly. “The Sintratec Kit allows us a whole new approach to the development of new medicines,” said Fabrizio Fina of FabRx.

Sintratec specializes in the development and production of SLS 3D printers. The range includes compact laser sintering systems that process high-quality polymers. Many hundreds of professional Sintratec machines are in operation around the world in various industries, universities, and research institutes.